The proportion of post-NAC surgical specimens with a DCIS component depended on BC subtype: 54.4% for HER2-positive BC, 53.3% for luminal BC, 24% for TNBC, p < 0.001 (Figure 2). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.